Cargando…

ODF4, MAGEA3, and MAGEB4: Potential Biomarkers in Patients with Transitional Cell Carcinoma

BACKGROUND: This study aimed to evaluate the diagnostic value of outer dense fiber 4 (ODF4), melanoma-associated antigen A3 (MAGEA3), and MAGEAB4 mRNAs in transitional cell carcinoma (TCC), using a small amount of cell reverse transcriptase-polymerase chain reaction (RT-PCR) on urinary exfoliated ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Afsharpad, Mandana, Nowroozi, Mohammad Reza, Ayati, Mohsen, Saffari, Mojtaba, Nemati, Saeed, Mohebbi, Elham, Nekoohesh, Leila, Zendehdel, Kazem, Modarressi, Mohammad Hossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pasteur Institute 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889501/
https://www.ncbi.nlm.nih.gov/pubmed/28865418
http://dx.doi.org/10.22034/ibj.22.3.160
_version_ 1783312709158174720
author Afsharpad, Mandana
Nowroozi, Mohammad Reza
Ayati, Mohsen
Saffari, Mojtaba
Nemati, Saeed
Mohebbi, Elham
Nekoohesh, Leila
Zendehdel, Kazem
Modarressi, Mohammad Hossein
author_facet Afsharpad, Mandana
Nowroozi, Mohammad Reza
Ayati, Mohsen
Saffari, Mojtaba
Nemati, Saeed
Mohebbi, Elham
Nekoohesh, Leila
Zendehdel, Kazem
Modarressi, Mohammad Hossein
author_sort Afsharpad, Mandana
collection PubMed
description BACKGROUND: This study aimed to evaluate the diagnostic value of outer dense fiber 4 (ODF4), melanoma-associated antigen A3 (MAGEA3), and MAGEAB4 mRNAs in transitional cell carcinoma (TCC), using a small amount of cell reverse transcriptase-polymerase chain reaction (RT-PCR) on urinary exfoliated cells. METHODS: We recruited a total of 105 suspected TCC patients and 54 sex- and age-matched non-TCC controls. The candidates’ genetic expression patterns were investigated with RT-PCR, while reverse transcription quantitative PCR was applied to quantify and compare each mRNA level between cases and control groups. RESULTS: The sensitivity of ODF4, MAGEA3, and MAGEAB4 RT-PCR was 54.8%, 63%, and 53.4%, whereas the specificity was 73.7%, 86%, and 94.7%, respectively. Combining ODF4, MAGEA3, and MAGEAB4 RT-PCR offered a relatively higher sensitivity (83.6%). CONCLUSION: RT-PCR with ODF4, MAGEA3, and MAGEAB4 on urinary exfoliated cells could provide clinicians with a promising method to improve TCC diagnosis, especially in the case of gross hematuria and catheterization. The method used here is non-invasive, simple and convenient, and unlike cytology, it does not rely directly on expert professional opinions. These features can be of particular importance to the management of TCC patients in whom regular and lifelong surveillance is required.
format Online
Article
Text
id pubmed-5889501
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Pasteur Institute
record_format MEDLINE/PubMed
spelling pubmed-58895012018-05-01 ODF4, MAGEA3, and MAGEB4: Potential Biomarkers in Patients with Transitional Cell Carcinoma Afsharpad, Mandana Nowroozi, Mohammad Reza Ayati, Mohsen Saffari, Mojtaba Nemati, Saeed Mohebbi, Elham Nekoohesh, Leila Zendehdel, Kazem Modarressi, Mohammad Hossein Iran Biomed J Full Length BACKGROUND: This study aimed to evaluate the diagnostic value of outer dense fiber 4 (ODF4), melanoma-associated antigen A3 (MAGEA3), and MAGEAB4 mRNAs in transitional cell carcinoma (TCC), using a small amount of cell reverse transcriptase-polymerase chain reaction (RT-PCR) on urinary exfoliated cells. METHODS: We recruited a total of 105 suspected TCC patients and 54 sex- and age-matched non-TCC controls. The candidates’ genetic expression patterns were investigated with RT-PCR, while reverse transcription quantitative PCR was applied to quantify and compare each mRNA level between cases and control groups. RESULTS: The sensitivity of ODF4, MAGEA3, and MAGEAB4 RT-PCR was 54.8%, 63%, and 53.4%, whereas the specificity was 73.7%, 86%, and 94.7%, respectively. Combining ODF4, MAGEA3, and MAGEAB4 RT-PCR offered a relatively higher sensitivity (83.6%). CONCLUSION: RT-PCR with ODF4, MAGEA3, and MAGEAB4 on urinary exfoliated cells could provide clinicians with a promising method to improve TCC diagnosis, especially in the case of gross hematuria and catheterization. The method used here is non-invasive, simple and convenient, and unlike cytology, it does not rely directly on expert professional opinions. These features can be of particular importance to the management of TCC patients in whom regular and lifelong surveillance is required. Pasteur Institute 2018-05 /pmc/articles/PMC5889501/ /pubmed/28865418 http://dx.doi.org/10.22034/ibj.22.3.160 Text en Copyright: © Iranian Biomedical Journal http://creativecommons.org/licenses/by/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Full Length
Afsharpad, Mandana
Nowroozi, Mohammad Reza
Ayati, Mohsen
Saffari, Mojtaba
Nemati, Saeed
Mohebbi, Elham
Nekoohesh, Leila
Zendehdel, Kazem
Modarressi, Mohammad Hossein
ODF4, MAGEA3, and MAGEB4: Potential Biomarkers in Patients with Transitional Cell Carcinoma
title ODF4, MAGEA3, and MAGEB4: Potential Biomarkers in Patients with Transitional Cell Carcinoma
title_full ODF4, MAGEA3, and MAGEB4: Potential Biomarkers in Patients with Transitional Cell Carcinoma
title_fullStr ODF4, MAGEA3, and MAGEB4: Potential Biomarkers in Patients with Transitional Cell Carcinoma
title_full_unstemmed ODF4, MAGEA3, and MAGEB4: Potential Biomarkers in Patients with Transitional Cell Carcinoma
title_short ODF4, MAGEA3, and MAGEB4: Potential Biomarkers in Patients with Transitional Cell Carcinoma
title_sort odf4, magea3, and mageb4: potential biomarkers in patients with transitional cell carcinoma
topic Full Length
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889501/
https://www.ncbi.nlm.nih.gov/pubmed/28865418
http://dx.doi.org/10.22034/ibj.22.3.160
work_keys_str_mv AT afsharpadmandana odf4magea3andmageb4potentialbiomarkersinpatientswithtransitionalcellcarcinoma
AT nowroozimohammadreza odf4magea3andmageb4potentialbiomarkersinpatientswithtransitionalcellcarcinoma
AT ayatimohsen odf4magea3andmageb4potentialbiomarkersinpatientswithtransitionalcellcarcinoma
AT saffarimojtaba odf4magea3andmageb4potentialbiomarkersinpatientswithtransitionalcellcarcinoma
AT nematisaeed odf4magea3andmageb4potentialbiomarkersinpatientswithtransitionalcellcarcinoma
AT mohebbielham odf4magea3andmageb4potentialbiomarkersinpatientswithtransitionalcellcarcinoma
AT nekooheshleila odf4magea3andmageb4potentialbiomarkersinpatientswithtransitionalcellcarcinoma
AT zendehdelkazem odf4magea3andmageb4potentialbiomarkersinpatientswithtransitionalcellcarcinoma
AT modarressimohammadhossein odf4magea3andmageb4potentialbiomarkersinpatientswithtransitionalcellcarcinoma